Outcome of Innate Pharma’s 2026 Annual General Meeting
MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) announced the voting results of its shareholders at the Annual General Meeting (“AGM”), which took place on May 21, 2026, in Marseille. All resolutions were voted. A total of 94 votes were cast out of a total of 34,872,293 … [Read more…]
